No Data
No Data
Ping An Securities: The updated policy for medical devices continues to be promoted, and domestic bidding and tendering are expected to significantly improve in the short term.
The update policy for medical field equipment is continuously advancing, and it is expected to gradually land in the second half of 2024. There is hope for significant improvement in domestic bidding and tendering in the short term.
Calculating The Intrinsic Value Of SonoScape Medical Corp. (SZSE:300633)
Nomura Adjusts SonoScape Medical's Price Target to 50.78 Yuan From 49.97 Yuan, Keeps at Buy
Does SonoScape Medical (SZSE:300633) Have A Healthy Balance Sheet?
Sonoscape Medical Corp. (300633.SZ): Repurchase completed, with a total expenditure of approximately 0.12 billion yuan to repurchase 2.89 million shares.
Sonoscape Medical Corp. (300633.SZ) announced on July 5th that, as of July 5th, 2024, the company has repurchased 2.89 million shares of the company's stock through centralized bidding trading, accounting for 0.67% of the company's current total equity. The highest closing price was 49.37 yuan/share, the lowest was 32.31 yuan/share, and the transaction amount was 12 billion yuan (excluding transaction fees). The actual timeframe for the company's stock repurchase is from November 21st, 2023 to July 5th, 2024. The repurchase plan has been completed.
SonoScape Medical Corp. (SZSE:300633) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
No Data